Regis Healthcare Limited

ASX:REG Stock Report

Market Cap: AU$1.8b

Regis Healthcare Future Growth

Future criteria checks 5/6

Regis Healthcare is forecast to grow earnings and revenue by 38.8% and 8.2% per annum respectively. EPS is expected to grow by 40.3% per annum. Return on equity is forecast to be 133% in 3 years.

Key information

38.8%

Earnings growth rate

40.3%

EPS growth rate

Healthcare earnings growth24.1%
Revenue growth rate8.2%
Future return on equity133.0%
Analyst coverage

Good

Last updated16 Dec 2024

Recent future growth updates

Recent updates

Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking

Dec 20
Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Sep 12
Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

May 02
Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Mar 21
At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Feb 28
Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 18
Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Aug 29
Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

Mar 01
Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Oct 27
Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Aug 26
Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Feb 25
Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

May 27
Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

May 09
Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?

Aug 10
Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?

At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?

Aug 10
At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?

Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years

Jul 14
Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years

Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?

Jul 02
Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?

Earnings and Revenue Growth Forecasts

ASX:REG - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20271,306841702257
6/30/20261,226651272037
6/30/20251,1465021987
6/30/20241,014-21187252N/A
3/31/2024947-18159224N/A
12/31/2023880-15132195N/A
9/30/2023830-2293150N/A
6/30/2023781-2854105N/A
3/31/2023761-453478N/A
12/31/2022741-611450N/A
9/30/2022733-504182N/A
6/30/2022725-3968115N/A
3/31/2022719-16N/AN/AN/A
12/31/20217138104143N/A
9/30/20217071496124N/A
6/30/20217012088105N/A
3/31/20217008N/AN/AN/A
12/31/2020699-486105N/A
9/30/2020688-287116N/A
6/30/2020678-188127N/A
3/31/202065521111156N/A
12/31/201966139134186N/A
9/30/201965445144203N/A
6/30/201964751155220N/A
3/31/201963251101204N/A
12/31/20186175047188N/A
9/30/201860652-13161N/A
6/30/201859454-74134N/A
3/31/201858656N/A129N/A
12/31/201757757N/A124N/A
9/30/201757159N/A138N/A
6/30/201756561N/A151N/A
3/31/201754755N/A151N/A
12/31/201652950N/A152N/A
9/30/201650548N/A143N/A
6/30/201648147N/A134N/A
3/31/201646859N/A146N/A
12/31/201545571N/A159N/A
9/30/201544664N/A143N/A
6/30/201543858N/A127N/A
3/31/201543328N/A119N/A
12/31/2014428-1N/A110N/A
9/30/20144190N/A122N/A
6/30/20144101N/A135N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: REG is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: REG is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: REG is expected to become profitable in the next 3 years.

Revenue vs Market: REG's revenue (8.2% per year) is forecast to grow faster than the Australian market (5.8% per year).

High Growth Revenue: REG's revenue (8.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: REG's Return on Equity is forecast to be very high in 3 years time (133%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 21:06
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Regis Healthcare Limited is covered by 19 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
William DunlopBofA Global Research
David StantonCLSA